c-MET Antikörper (AA 1232-1236)
(2 Referenzen)-
- Target Alle c-MET (MET) Antikörper anzeigen
- c-MET (MET) (Met Proto-Oncogene (MET))
-
Bindungsspezifität
- AA 1232-1236
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser c-MET Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Spezifität
- The antibody detects endogenous level of total Met protein.
- Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography usingepitope-specific immunogen.
- Immunogen
- Peptide sequence around AA 1232-1236 (K-E-Y-Y-S) derived from Human Met. Antibodies were produced by immunizing rabbits with synthetic peptide and KLH conjugates.
- Isotyp
- IgG
- Top Product
- Discover our top product MET Primärantikörper
-
anti-Met Proto-Oncogene (MET) (AA 25-150) antibody
MET Reaktivität: Human, Maus WB, ELISA, IHC (p), FACS, IF (cc), IF (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Met Proto-Oncogene (MET) (AA 743-932) antibodyMET Reaktivität: Human WB, ELISA, IHC, FACS, ICC Wirt: Maus Monoclonal 5E9C4 unconjugated
anti-Met Proto-Oncogene (MET) (AA 1092-1379) antibodyMET Reaktivität: Human WB, IHC, ICC, IP Wirt: Kaninchen Polyclonal unconjugated
anti-Met Proto-Oncogene (MET) antibodyMET Reaktivität: Human WB, ELISA, IHC, IF, FACS Wirt: Kaninchen Monoclonal 2D12 unconjugated Recombinant Antibody
anti-Met Proto-Oncogene (MET) (AA 743-932) antibodyMET Reaktivität: Human ELISA, FACS, ICC Wirt: Maus Monoclonal 5E9B7 unconjugated
anti-Met Proto-Oncogene (MET) (C-Term) antibodyMET Reaktivität: Human WB, IF, ICC, IP Wirt: Kaninchen Polyclonal unconjugated
anti-Met Proto-Oncogene (MET) (Internal Region) antibodyMET Reaktivität: Human, Maus, Ratte WB, ELISA, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Met Proto-Oncogene (MET) (Tyr1003) antibodyMET Reaktivität: Human WB, ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Met Proto-Oncogene (MET) (AA 83-209) antibodyMET Reaktivität: Human ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Met Proto-Oncogene (MET) (Catalytic Domain) antibodyMET Reaktivität: Human, Maus WB, IF, IHC (p) Wirt: Maus Monoclonal 4AT44 unconjugated
-
- Applikationshinweise
- Western blotting: 1:500-1:1000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- Phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
: "MicroRNA-449a is downregulated in non-small cell lung cancer and inhibits migration and invasion by targeting c-Met." in: PLoS ONE, Vol. 8, Issue 5, pp. e64759, (2013) (PubMed).
: "miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells." in: Cancer letters, Vol. 275, Issue 1, pp. 44-53, (2009) (PubMed).
-
: "MicroRNA-449a is downregulated in non-small cell lung cancer and inhibits migration and invasion by targeting c-Met." in: PLoS ONE, Vol. 8, Issue 5, pp. e64759, (2013) (PubMed).
-
- Target
- c-MET (MET) (Met Proto-Oncogene (MET))
- Andere Bezeichnung
- Met (MET Produkte)
- Hintergrund
- Receptor for hepatocyte growth factor and scatter factor. Has a tyrosine-protein kinase activity. Functions in cell proliferation, scattering, morphogenesis and survival.
- Molekulargewicht
- 156 kDa
- NCBI Accession
- NP_000236
- UniProt
- P08581
- Pathways
- RTK Signalweg, Carbohydrate Homeostasis, Synaptic Membrane, Signaling of Hepatocyte Growth Factor Receptor
-
